(L07–L17) Late-Breaking Abstract Poster

Late-breaking abstract poster session.

Presentations:

• 1:00 PM – 3:00 PM Eastern Time

  Telitacicept, a Human Recombinant Fusion Protein Targeting B Lymphocyte Stimulator (BlyS) and a Proliferation-Inducing Ligand (APRIL), in Systemic Lupus Erythematosus (SLE): Results of a Phase 3 Study
  

  Late-Breaking Poster Presenter: Dan Ross, MBA – RemeGen
• 1:00 PM – 3:00 PM Eastern Time

  Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders
  

  Late-Breaking Poster Presenter: Christopher Podgorski, MD – Washington University/B-JH/SLCH Consortium
• 1:00 PM – 3:00 PM Eastern Time

  Impact on Access to Methotrexate in the Post-Roe Era
  

  Late-Breaking Poster Presenter: Kristin Wipfler, PhD – FORWARD, The National Databank for Rheumatic Diseases
• 1:00 PM – 3:00 PM Eastern Time

  Efgartigimod Prevents Necrosis and Allows for Muscle Fiber Regeneration in a Humanized Mouse Model of Immune-mediated Necrotizing Myopathy (IMNM)
  

  Late-Breaking Poster Presenter: Bas van der Woning, PhD – argenx BV
• 1:00 PM – 3:00 PM Eastern Time

  WITHDRAWN
• 1:00 PM – 3:00 PM Eastern Time

  First Line Treatment Using Recombinant IL-1Receptor Antagonist in New Onset Systemic Juvenile Idiopathic Arthritis Is an Effective Treatment Strategy, Irrespective of HLA DRB1 Background
  

  Late-Breaking Poster Presenter: Sebastiaan Vastert, MD, PhD – University Medical Center Utrecht
• 1:00 PM – 3:00 PM Eastern Time

  Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block
  

  Late-Breaking Poster Presenter: Robert Hamilton, MD, MHS – Hospital for Sick Children
• 1:00 PM – 3:00 PM Eastern Time

  Bimekizumab Maintains Improvements in Efficacy Endpoints and Has a Consistent Safety Profile Through 52 Weeks in Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis: Results from Two Parallel Phase 3 Studies
  

  Late-Breaking Poster Presenter: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne
• 1:00 PM – 3:00 PM Eastern Time

  Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis: A Randomized Phase IIIb Study
  

  Late-Breaking Poster Presenter: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne
• 1:00 PM – 3:00 PM Eastern Time

  Innovative Anti-pneumococcal Vaccine Strategies versus Standard Vaccination Regimen in Patients with ANCA-associated Vasculitides Receiving Rituximab Therapy: A Multicenter Randomized Controlled Trial (PNEUMOVAS)
  

  Late-Breaking Poster Presenter: Benjamin Terrier, MD, PhD – Cochin Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Evaluating the Safety and Factors Associated with Treatment Cessation in Takayasu Arteritis
  

  Late-Breaking Poster Presenter: Robert Maughan, PhD, BSc – Imperial College London